COBRRA trial News

Latest Articles

• International COBRRA Trial Identifies Apixaban as Superior Anticoagulant for Reducing Severe Bleeding Risk in Venous Thrombosis Patients

  Published: Mar 13, 2026

  Section: Health

  The first head-to-head clinical trial comparing standard blood clot treatments has found that apixaban carries less than half the bleeding risk of rivaroxaban. Led by The Ottawa Ho...